Basic information Safety Supplier Related

5-BROMO-IMIDAZO[1,2-A]PYRIDINE

Basic information Safety Supplier Related

5-BROMO-IMIDAZO[1,2-A]PYRIDINE Basic information

Product Name:
5-BROMO-IMIDAZO[1,2-A]PYRIDINE
Synonyms:
  • 5-BROMO-IMIDAZO[1,2-A]PYRIDINE
  • 5-BROMOIMIDAZO[1,2-A]PYRIDINE, 95+%
  • 5-bromoH-imidazo[1,2-a]pyridine
  • 5-BROMO-5H-IMIDAZO[2,1-B][1,3]OXAZINE
  • 5-Bromo-1,5-dihydroimidazo[1,2-a]pyridine
  • Imidazo[1,2-a]pyridine, 5-bromo-
  • 5-Bromoimidazo[1,2-a]pyridine
CAS:
69214-09-1
MF:
C7H5BrN2
MW:
197.03
EINECS:
1592732-453-0
Product Categories:
  • API intermediates
  • Heterocycle-Pyridine series
  • Building Blocks
  • Imidazo[x,x-y]pyridine
Mol File:
69214-09-1.mol
More
Less

5-BROMO-IMIDAZO[1,2-A]PYRIDINE Chemical Properties

Melting point:
61-64℃
Density 
1.69±0.1 g/cm3(Predicted)
storage temp. 
Keep in dark place,Sealed in dry,Room Temperature
solubility 
Chloroform (Slightly), DMSO (Slightly)
form 
Solid
pka
5.15±0.50(Predicted)
color 
Pale Brown to Light Brown
InChI
InChI=1S/C7H5BrN2/c8-6-2-1-3-7-9-4-5-10(6)7/h1-5H
InChIKey
CCOFGVWHMYYDBG-UHFFFAOYSA-N
SMILES
C12=NC=CN1C(Br)=CC=C2
More
Less

Safety Information

WGK Germany 
3
HS Code 
2933599590
More
Less

5-BROMO-IMIDAZO[1,2-A]PYRIDINE Usage And Synthesis

Uses

5-Bromoimidazo[1,2-a]pyridine can be used as HPK1 antagonists to treat HPK1-mediated disorders.

Synthesis

603301-13-9

69214-09-1

General procedure for the synthesis of 5-bromoimidazo[1,2-a]pyridines from 5-bromoimidazo[1,2-a]pyridine hydrobromide: 1. Preparation of reactants: 2-bromo-1,1-diethoxyethane (3.64 g, 18.48 mmol) was added to a solution of 6-bromopyridin-2-ylamine (1.0 g, 5.77 mmol) in n-butanol (40 mL). 2. Reaction conditions: the mixture was refluxed overnight and then cooled to room temperature. 3. post-processing: the reaction mixture was filtered to give 1.3 g (81% yield) of 5-bromoimidazo[1,2-a]pyridine hydrobromide as a white solid. esms (M + +1): 198.9 m/z. 4. Neutralization step: Saturated sodium bicarbonate solution (300 mL) was added to an ethyl acetate suspension of 5-bromoimidazo[1,2-a]pyridine hydrobromide (13.0 g, 46.96 mmol). 5. Isolation and purification: the organic layer was separated, washed with saturated sodium bicarbonate solution, dried with magnesium sulfate and concentrated under reduced pressure to give 9.7 g (100% yield) of 5-bromoimidazo[1,2-a]pyridine as a white solid.

References

[1] Patent: WO2003/76398, 2003, A2. Location in patent: Page/Page column 20
[2] Patent: WO2003/76442, 2003, A1. Location in patent: Page/Page column 40

5-BROMO-IMIDAZO[1,2-A]PYRIDINESupplier

Jiangyin Lesen Biotechnology Co., Ltd. Gold
Tel
18961626312
Email
125393839@qq.com
Hubei Zhixin Biopharmaceutical Technology Co., Ltd. Gold
Tel
13163286261
Email
18672992087@163.cn
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Alfa Aesar
Tel
400-6106006
Email
saleschina@alfa-asia.com
Pure Chemistry Scientific Inc.
Tel
001-857-928-2050 or 1-888-588-9418
Email
sales@chemreagents.com